$Novo Nordisk AS(NVO.US) Recently, the tech sector has been adjusting, while the healthcare and consumer sectors have been relatively strong. It's important to pay attention to the Fed's speech early this morning—whether it leans dovish or hawkish will determine if the tech sector continues to adjust. Novo Nordisk didn't even pull back to the 5-day moving average yesterday. The previous accumulation zone around 54.5 has now turned into support. The next target is the 30-day moving average; if it breaks and holds above that, the next target is around 64 near the 60-day moving average. Beyond that, there's resistance from the accumulation zone before the earnings crash, so breaking through might be tough. In short, first target 57, then 64. I'll be trading the stock and the 60-strike calls expiring on 0919 at these levels, especially the short calls, which are nearing expiration—I'll clear the remaining contracts soon. For other holdings like $Unitedhealth(UNH.US), I expect consolidation around 300 to digest the accumulation. If it tests support, I'll add to my position. $Taiwan Semiconductor(TSM.US), $Microsoft(MSFT.US), and $Alphabet(GOOGL.US) are all AI-related and heavily influenced by Nvidia. Watch Nvidia's movement—if there's a sharp drop, I'll add at predetermined levels. Currently, TSMC and Google's P/E ratios aren't high, but opportunities like April's steep discounts don't come every year. The movement of $Rocket Lab(RKLB.US) is hard to read. If it drops to my target price, I'll add more shares and might buy the 2601116 calls at the right level. No matter how the Fed delays, the high U.S. debt means a rate-cut cycle is inevitable. During this cycle, converting cash into quality assets is the best way to preserve and grow wealth. Research and pick your stocks, buy on dips, and wait patiently for the payoff. Wishing everyone's investment accounts steady growth and big profits in this rate-cut cycle.